Company Filing History:
Years Active: 2015-2017
Title: Axel Harrenga: Innovator in Prolactin Receptor Antibodies
Introduction
Axel Harrenga, an inventive mind located in Wuppertal, Germany, has made significant contributions to the field of biomedicine. With a total of five patents to his name, his work primarily focuses on the therapeutic use of neutralizing prolactin receptor antibodies, providing promising solutions for a variety of benign disorders.
Latest Patents
Among his most notable inventions are the neutralizing prolactin receptor antibody Mat3 and its therapeutic applications. This invention is crucial for developing treatment methods for conditions such as endometriosis, adenomyosis, non-hormonal female contraception, benign breast disease, and others. The antibody blocks prolactin receptor-mediated signaling, representing a significant advancement in therapeutic options. Another innovative patent addresses the neutralizing prolactin receptor antibody 006-H08, along with its maturated forms and binding fragments. This invention similarly offers advantages in treating benign disorders linked to the prolactin receptor, further expanding the potential applications for managing female health.
Career Highlights
Axel Harrenga has worked at renowned organizations, including Bayer Intellectual Property GmbH and Seattle Genetics, Inc. His expertise in developing antibodies and pharmaceutical compositions has positioned him as an influential figure in therapeutic innovation, particularly in women's health and oncology.
Collaborations
Throughout his career, Harrenga has collaborated with esteemed colleagues like Simone Greven and Christiane Otto. These partnerships have fostered a creative and innovative research environment, leading to breakthroughs in the understanding and treatment of conditions mediated by prolactin.
Conclusion
Axel Harrenga's contributions to the biomedical field, particularly through his patents involving prolactin receptor antibodies, underline the importance of innovation in medicine. His work not only showcases his dedication as an inventor but also holds the promise of significant benefits for patients dealing with various health complications. As he continues to develop new solutions, the impact of his inventions is likely to grow, solidifying his legacy as a prominent figure in biomedical innovation.